ArticleBMJ global health2022
Innovations in cost-effectiveness analysis that advance equity can expand its use in health policy.
Article in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Automating cost-effectiveness models with agentic artificial intelligence: Case study and implications for value assessment.Journal of managed care & specialty pharmacy · 2026Article
- Lung Cancer Screening in a Population from Northeast Italy Exposed to Both Asbestos and Smoking: A Cost-Effectiveness Analysis.Journal of clinical medicine · 2026Article
- Advancing health equity: Why guideline development must prioritize fairness and justice.Clinical and public health guidelines · 2025Article
- Legal and systemic implications of the 2023 Polish act on certain medical professions-regulation, workforce requirements, healthcare system impact.Frontiers in public health · 2025Review
- Connecting Female Entertainment Workers in Cambodia to Health Care Services Using mHealth: Economic Evaluation of Mobile Link.JMIR formative research · 2024Article
- Estimating and Rewarding the Value of Healthcare Interventions Beyond the Healthcare Sector: A Conceptual Framework.PharmacoEconomics · 2024Article
- A QALY is [still] a QALY is [still] a QALY? : Evaluating proportional shortfall as the answer to the problem of equity in healthcare allocations.BMC medical ethics · 2024Article
- Cost-Effectiveness Analysis of Pharmacist Adherence Interventions in People Living with HIV/AIDS in Pakistan.Healthcare (Basel, Switzerland) · 2023Article
- Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo.BMJ global health · 2023Article
- A Scoping Review of Economic Evaluations to Inform the Reorientation of Preventive Health Services in Australia.International journal of environmental research and public health · 2023Article
- Cost-effectiveness analysis of overground robotic training versus conventional locomotor training in people with spinal cord injury.Journal of neuroengineering and rehabilitation · 2023Article
- Health Inequalities: To What Extent are Decision-Makers and Economic Evaluations on the Same Page? An English Case Study.Applied health economics and health policy · 2022Article
- Economic Evaluations of Speech and Language Therapy Interventions: A Scoping Review.International journal of language & communication disordersArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.